The following is a summary of “Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder ...

N1 Single lymph node metastasis, 2 cm or less in greatest dimension ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99 ...

While prostate cancer affects about 1 in 8 men, when it's caught early, there's a 99% survival rate, according to Cancer.org.

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses. Patients with recurrent low-grade intermediate-risk ...

He was diagnosed with stage-2 bladder cancer and started treatment. That summer, his urologist said he needed a surgery ...

The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification of Diseases, 10th Revision [ICD-10] codes ...

More than one third of patients receiving first-line chemotherapy for metastatic bladder cancer did not have guideline-recommended treatment adherence.

Last year, for example, the results of the PACIFIC-2 study were unable to ... a perioperative option in resectable stage IIA to IIIB NSCLC cases. Bladder cancer hopes back on track There was ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.